TGFB1 and neoplasm: In contrast, the primary spleen tumor masses were comparable between WT and Cbl-b−/− mice in all of the experiments (Figure 7D), suggesting that Cbl-b−/− mice are not generally capable of eliminating the B16 melanoma based on their resistance to TGF-β or Tregs (7–11).